Literature DB >> 11372682

Extracellular nucleotides ATP and UTP induce a marked acute release of tissue-type plasminogen activator in vivo in man.

T Hrafnkelsdóttir1, D Erlinge, S Jern.   

Abstract

Extracellular nucleotides such as ATP and UTP are released by activation of platelets and ischemic tissue injury. The aim of the present study was to investigate whether ATP and UTP can induce acute tPA release from the vascular endothelium in vivo. Nine healthy subjects were studied in a perfused-forearm model during stepwise intraarterial infusions of ATP and UTP (10-200 nmol/min), and UTP during inhibition of prostanoid and NO synthesis by indomethacin and L-NMMA. ATP and UTP induced a similar and marked stimulation of forearm tPA release which increased 11- and 18-fold above baseline (p < or =0.01 for both) in conjunction with pronounced vasodilation. Neither the acute tPA release nor the vasodilation could be abrogated by NO and prostanoid synthesis inhibition. The similar effect of ATP and UTP suggests that P2Y rather than adenosine receptors mediate the response. Release of extracellular nucleotides in ischemic tissue may induce a pronounced activation of the endogenous fibrinolytic system.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11372682

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  18 in total

1.  Extracellular nucleotides induce vasodilatation in human arteries via prostaglandins, nitric oxide and endothelium-derived hyperpolarising factor.

Authors:  Anna-Karin Wihlborg; Malin Malmsjö; Atli Eyjolfsson; Ronny Gustafsson; Kenneth Jacobson; David Erlinge
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

Review 2.  Adenosine receptor agonists for promotion of dermal wound healing.

Authors:  María D Valls; Bruce N Cronstein; M Carmen Montesinos
Journal:  Biochem Pharmacol       Date:  2008-11-12       Impact factor: 5.858

Review 3.  Cellular mechanisms of tissue fibrosis. 6. Purinergic signaling and response in fibroblasts and tissue fibrosis.

Authors:  David Lu; Paul A Insel
Journal:  Am J Physiol Cell Physiol       Date:  2013-12-18       Impact factor: 4.249

4.  P2Y₂ receptor activation decreases blood pressure and increases renal Na⁺ excretion.

Authors:  Timo Rieg; Maria Gerasimova; José L Boyer; Paul A Insel; Volker Vallon
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-05-25       Impact factor: 3.619

5.  Promotion of Wound Healing by an Agonist of Adenosine A2A Receptor Is Dependent on Tissue Plasminogen Activator.

Authors:  M Carmen Montesinos; Avani Desai-Merchant; Bruce N Cronstein
Journal:  Inflammation       Date:  2015-12       Impact factor: 4.092

6.  Hypothermia in cardiogenic shock reduces systemic t-PA release.

Authors:  Jesper van der Pals; Michael I Götberg; Matthias Götberg; Lillemor Mattsson Hultén; Mia Magnusson; Sverker Jern; David Erlinge
Journal:  J Thromb Thrombolysis       Date:  2011-07       Impact factor: 2.300

Review 7.  P2 receptors: new potential players in atherosclerosis.

Authors:  Francesco Di Virgilio; Anna Solini
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

8.  P2Y₂ receptor activation decreases blood pressure via intermediate conductance potassium channels and connexin 37.

Authors:  J A Dominguez Rieg; J M Burt; P Ruth; T Rieg
Journal:  Acta Physiol (Oxf)       Date:  2015-01-08       Impact factor: 6.311

9.  Mild hypothermia markedly reduces ischemia related coronary t-PA release.

Authors:  Jesper van der Pals; Matthias Götberg; Göran K Olivecrona; Helen Brogren; Sverker Jern; David Erlinge
Journal:  J Thromb Thrombolysis       Date:  2010-04       Impact factor: 2.300

10.  Positive inotropic effects by uridine triphosphate (UTP) and uridine diphosphate (UDP) via P2Y2 and P2Y6 receptors on cardiomyocytes and release of UTP in man during myocardial infarction.

Authors:  Anna-Karin Wihlborg; Johanna Balogh; Lingwei Wang; Catharina Borna; Ying Dou; Bhalchandra V Joshi; Eduardo Lazarowski; Kenneth A Jacobson; Anders Arner; David Erlinge
Journal:  Circ Res       Date:  2006-03-16       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.